US 10724026
Engineered primate L-methioninase for therapeutic purposes
granted A61KA61K35/12A61K38/51
Quick answer
US patent 10724026 (Engineered primate L-methioninase for therapeutic purposes) held by The Board of Regents of the University of Texas System expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K35/12, A61K38/51, A61K45/06, A61P